|
Improving Access to
Breast Cancer Clinical Trials
Chemotherapy:
Combination
Chemotherapy With or Without Trastuzumab in Treating Women With
Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage
IIIA breast cancer
Comparison
of Combination Chemotherapy Regimens in Treating Older Women Who
Have Undergone Surgery for Breast Cancer
Conditions: stage II breast cancer; stage IIIA breast cancer
Chemotherapy
Decisions and Outcomes in Older Women With Newly Diagnosed Breast
Cancer
Conditions: Quality of Life; psychosocial effects/treatment; stage
II breast cancer; stage IIIA breast cancer
Zoledronate
in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy
After Surgery For Early Stage Breast Cancer
Conditions: Osteoporosis; stage I breast cancer; stage II breast
cancer
Amonafide
in Treating Women With Metastatic Breast Cancer That Has Progressed
After Previous Chemotherapy
Conditions: stage IV breast cancer; recurrent breast cancer
Diagnostic
Procedures in Women With Locally Advanced Breast Cancer Who Are
Receiving Chemotherapy Before Breast Cancer Surgery
Conditions: stage II breast cancer; stage IV breast cancer; stage
IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast
cancer; ...
Magnetic
Resonance Imaging in Women Receiving Chemotherapy for Stage III
Breast Cancer
Conditions: stage IIIA breast cancer; stage IIIB breast cancer;
stage IIIC breast cancer
Combination
Chemotherapy With or Without Trastuzumab in Treating Women With
Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer
Use
of Neulasta with chemotherapy in elderly patients with cancer
Jamaica; Biomedical Research Alliance of New York
The
goals of Study 6657 are to investigate the validity of breast MRI
as a staging tool for patients undergoing neoadjuvant chemotherapy
and to quantify early responses to therapy using MRI measurements
of volume and contrast kinetics.
New York; Memorial Sloan-Kettering Cancer Center
Phase
II Study of High-Dose Chemotherapy, Total Body Irradiation, and
Autologous Peripheral Blood or Bone Marrow Transplantation in Patients
With Hematologic Malignancies or Selected Chemosensitive Solid Tumors
Phase
III Randomized Study of Zoledronate, Calcium, and Cholecalciferol
(Vitamin D) to Prevent Bone Loss in Women With Breast Cancer Receiving
Adjuvant Chemotherapy
Phase
III Randomized Study of Zoledronate for the Prevention of Bone Loss
in Premenopausal Women Receiving Adjuvant Chemotherapy For Early
Stage Breast Cancer
Phase
III Randomized Study of Goserelin for the Reduction of Premature
Ovarian Failure in Women With Stage I-IIIA Hormone Receptor-Negative
Breast Cancer Undergoing Adjuvant Chemotherapy
Phase
III Study of Standard Adjuvant Chemotherapy versus Capecitabine
in Women 65 Years & Older with Early-Stage Breast Cancer
Phase
III Trial of Zoledronic Acid (Zometa) to Prevent Bone Loss in Patients
with Localized Breast Cancer Who Have Chemotherapy-Induced Ovarian
Failure
Source: http://www.cancer.gov/ClinicalTrials/,
http://www.centerwatch.org,
http://www.Clinicaltrials.gov
If you are
interested in participating in a Breast Cancer Clinical Trial call
CDN at: (212) 382-0699, ext. 227.
Treatment
Chemotherapy
Homeopathic
Lymph Node Removal
Other Treatments: Pharmaceutical
Radiation Therapy
Treatment Drugs
Prevention
& Screening & Diagnostic
Imaging
Mammography
Prevention of Breast Cancer
Postmenopausal/ Older Women Patients
Genetics
Genetic trials
Quality
of Life/ Supportive Care
Support
Groups for Heterosexual Women with Breast Cancer & Lesbian Women
with Breast Cancer
|
